Mumbai, Feb. 3 -- NATCO Pharma received tentative approval from the USFDA for Erdafitinib, 3 mg, 4mg, and 5 mg, a generic version of Balversa(R) by Janssen Biotech Inc.

Published by HT Digital Content Services with permission from Capital Market....